StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

Research analysts at StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Trading Down 15.8 %

Shares of CUTR stock opened at $0.10 on Monday. The business’s fifty day simple moving average is $0.42 and its 200-day simple moving average is $0.52. The company has a market cap of $1.99 million, a PE ratio of -0.01 and a beta of 1.36. Cutera has a 12-month low of $0.09 and a 12-month high of $3.00.

Hedge Funds Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Geode Capital Management LLC lifted its position in Cutera, Inc. (NASDAQ:CUTR) by 25.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 248,257 shares of the medical device company’s stock after acquiring an additional 50,046 shares during the period. Geode Capital Management LLC owned 1.23% of Cutera worth $88,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 90.70% of the stock is currently owned by hedge funds and other institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.